Achieve Life Sciences (ACHV) Non-cash Items (2012 - 2026)

Achieve Life Sciences has disclosed Non-cash Items across 15 years of filings, most recently posting $9.1 million for Q1 2026.

• Quarterly Non-cash Items rose 295.65% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 295.65% YoY) and the FY2025 annual result came in at $2.9 million, up 20.83% from the prior year.
• Non-cash Items advanced to $9.1 million in Q1 2026, from $2.9 million in the prior quarter.
• Over five years, Non-cash Items peaked at $9.1 million in Q1 2026 and troughed at $1.7 million in Q3 2025.
• A 5-year average of $3.7 million and a median of $3.5 million in 2024 frame the typical range for Non-cash Items.
• Annual changes were most pronounced in 2025 — Non-cash Items tumbled 46.51% — and 2026, when it soared 295.65%.
• Tracing ACHV's Non-cash Items over 5 years: stood at $3.2 million in 2022, then grew by 6.25% to $3.4 million in 2023, then fell by 29.41% to $2.4 million in 2024, then gained by 20.83% to $2.9 million in 2025, then jumped by 213.79% to $9.1 million in 2026.
• Business Quant data shows ACHV's Non-cash Items at $9.1 million in Q1 2026, $2.9 million in Q4 2025, and $1.7 million in Q3 2025.